Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Murayama, H. Hirata, T. Fukuda, M. Arima (Tochigi, Chiba, Japan). Leukotriene (LT)C₄ aggravate bleomycin-induced pulmonary fibrosis in mice. Eur Respir J 2012; 40: Suppl. 56, 2319

Member's Comments

No comment yet.

Related content which might interest you: 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Effects of drotrecogin-alpha on the bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice via decreasing MCP-1 mRNA Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Danshenextract salt Inhibits bleomycin-induced experimental pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Antifibrotic effects of Lck inhibition on bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Metformin attenuates bleomycin-induced pulmonary fibrosis in mice via IGF-1 suppression Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013